Latest News from: Johns Hopkins Medicine

Filters close
Newswise: Study Identifies Biomarker for Allergic Reaction in Kidneys
Released: 5-Jul-2023 10:00 AM EDT
Study Identifies Biomarker for Allergic Reaction in Kidneys
Johns Hopkins Medicine

In a study led by Johns Hopkins Medicine, in collaboration with Yale School of Medicine, researchers have identified a biomarker found via a simple urine test that can be used to diagnose acute tubulointerstitial nephritis (AIN), a medical condition that causes inflammation of the kidneys and can lead to acute kidney injury (AKI) — a sudden loss of kidney function. Experts say a kidney biopsy is often required to diagnose AIN because there are no disease-specific signs or symptoms.

Newswise: Martin/Hopkins Method to Calculate LDL Or ‘Bad’ Cholesterol Outperforms Other Equations, Study Shows
Released: 3-Jul-2023 10:00 AM EDT
Martin/Hopkins Method to Calculate LDL Or ‘Bad’ Cholesterol Outperforms Other Equations, Study Shows
Johns Hopkins Medicine

In a new large, comprehensive analysis that looked at data from more than 5 million patients, the Martin/Hopkins method developed by Johns Hopkins researchers to calculate low-density lipoprotein (LDL) cholesterol — so-called bad cholesterol — produces higher accuracy rates than the nearly two dozen other available equations.

Newswise: Scientists Design a Nanoparticle That May Improve mRNA Cancer Vaccines
Released: 28-Jun-2023 9:30 AM EDT
Scientists Design a Nanoparticle That May Improve mRNA Cancer Vaccines
Johns Hopkins Medicine

Johns Hopkins Medicine scientists say they have developed a nanoparticle — an extremely tiny biodegradable container — that has the potential to improve the delivery of messenger ribonucleic acid (mRNA)-based vaccines for infectious diseases such as COVID-19, and vaccines for treating non-infectious diseases including cancer.

Newswise: Deaf Mice Have Nearly Normal Inner Ear Function Until Ear Canal Opens
26-Jun-2023 12:05 PM EDT
Deaf Mice Have Nearly Normal Inner Ear Function Until Ear Canal Opens
Johns Hopkins Medicine

For the first two weeks of life, mice with a hereditary form of deafness have nearly normal neural activity in the auditory system, according to a new study by Johns Hopkins Medicine scientists. Their previous studies indicate that this early auditory activity — before the onset of hearing — provides a kind of training to prepare the brain to process sound when hearing begins.

Newswise: Poor Sense of Smell Linked to Increased Risk of Depression in Older Adults
Released: 26-Jun-2023 10:00 AM EDT
Poor Sense of Smell Linked to Increased Risk of Depression in Older Adults
Johns Hopkins Medicine

In a study that followed more than 2,000 community-dwelling older adults over eight years, researchers at Johns Hopkins Medicine say they have significant new evidence of a link between decreased sense of smell and risk of developing late-life depression.

Newswise: Study Sets New Standard for Graft-Versus-Host Disease Prevention After Stem Cell Transplant
Released: 22-Jun-2023 1:15 PM EDT
Study Sets New Standard for Graft-Versus-Host Disease Prevention After Stem Cell Transplant
Johns Hopkins Medicine

Clinicians have a new standard for graft-versus-host disease (GVHD) prevention after allogeneic hematopoietic stem cell transplantation, according to results from a phase III study published in the New England Journal of Medicine. The new standard is more effective at preventing GVHD and came with less side effects, compared with the current gold standard.

Newswise: New Findings Show Mitochondrial DNA Fragments in Blood as Important Biomarkers for Aging and Inflammation
Released: 21-Jun-2023 10:00 AM EDT
New Findings Show Mitochondrial DNA Fragments in Blood as Important Biomarkers for Aging and Inflammation
Johns Hopkins Medicine

In an eight-year study of more than 600 community-dwelling older adults, Johns Hopkins Medicine researchers say they have further linked levels of cell-free DNA (DNA fragments resulting from cell death) circulating in the blood to chronic inflammation and frailty.

Newswise: Study Finds Female Babies with Congenital Diaphragmatic Hernia Have Slightly Higher Risk of Death
Released: 19-Jun-2023 3:30 PM EDT
Study Finds Female Babies with Congenital Diaphragmatic Hernia Have Slightly Higher Risk of Death
Johns Hopkins Medicine

A Johns Hopkins Children Center study using medical records from an international registry concludes that female babies with congenital diaphragmatic hernia (CDH) are slightly more likely to die within 30 to 60 days of birth than male babies with the same condition.

Not for public release

This news release is embargoed until 14-Jun-2023 11:00 AM EDT Released to reporters: 13-Jun-2023 12:10 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 14-Jun-2023 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Black, Hispanic Survivors of Breast Cancer Have Higher Death Rates from Second Cancers
Released: 9-Jun-2023 10:00 AM EDT
Black, Hispanic Survivors of Breast Cancer Have Higher Death Rates from Second Cancers
Johns Hopkins Medicine

Hispanic and non-Hispanic Black female survivors of breast cancer experience higher death rates after being diagnosed with a second primary cancer than members of other ethnic and racial groups, according to recent research from investigators at the Johns Hopkins Kimmel Cancer Center.

Newswise: Study Finds Functional Limitations Increasing in Survivors of Cancer
Released: 7-Jun-2023 10:00 AM EDT
Study Finds Functional Limitations Increasing in Survivors of Cancer
Johns Hopkins Medicine

The percentage of survivors of cancer reporting functional limitations in the United States has more than doubled over the past 20 years, according to a new study in the journal JAMA Oncology. The work, published May 11, was a collaborative effort from investigators at the Johns Hopkins Kimmel Cancer Center, the Dell Medical School in Austin, Texas, and the University of Minnesota’s Masonic Cancer Center in Minneapolis.

Newswise: Scientists Use Machine Learning to ‘See’ How the Brain Adapts to Different Environments
Released: 5-Jun-2023 11:05 AM EDT
Scientists Use Machine Learning to ‘See’ How the Brain Adapts to Different Environments
Johns Hopkins Medicine

Johns Hopkins scientists have developed a method involving artificial intelligence to visualize and track changes in the strength of synapses — the connection points through which nerve cells in the brain communicate — in live animals. The technique, described in Nature Methods, should lead, the scientists say, to a better understanding of how such connections in human brains change with learning, aging, injury and disease.

   
Newswise: 'Tipping The Balance’ Of Immune Cells from Bad to Good Reverses Multiple Sclerosis Symptoms in Mice
Released: 2-Jun-2023 2:20 PM EDT
'Tipping The Balance’ Of Immune Cells from Bad to Good Reverses Multiple Sclerosis Symptoms in Mice
Johns Hopkins Medicine

According to the federal government’s National Institute of Neurological Disorders and Stroke, nearly 3 million people worldwide — with almost a third in the United States — are living with multiple sclerosis (MS), a disabling neurological disease in which the body’s immune system mistakenly attacks nerves feeding information to the central nervous system (the brain and spinal cord). Although rarely fatal, MS can lead to long-term disabilities, and impair movement, muscle control, vision and cognition.

Newswise: Heart Attacks Associated with Faster Cognitive Decline Over Years
Released: 31-May-2023 9:00 AM EDT
Heart Attacks Associated with Faster Cognitive Decline Over Years
Johns Hopkins Medicine

In a recent study, a Johns Hopkins Medicine researcher and collaborators analyzed data on adults to determine if there is a link between having a heart attack and cognitive decline.

Newswise: Researchers Use ‘Natural’ System to Identify Proteins Most Useful For Developing an Effective HIV Vaccine
Released: 30-May-2023 2:00 PM EDT
Researchers Use ‘Natural’ System to Identify Proteins Most Useful For Developing an Effective HIV Vaccine
Johns Hopkins Medicine

Scientists have spent years trying to develop an effective HIV vaccine, but none have proven successful. Based on findings from a recently published study, a Johns Hopkins Medicine-led research team may have put science one step closer to that goal.

Newswise: Experimental Drug Inhibits or Prevents Diabetic Eye Disease in Wilmer Eye Institute Study
Released: 25-May-2023 2:00 PM EDT
Experimental Drug Inhibits or Prevents Diabetic Eye Disease in Wilmer Eye Institute Study
Johns Hopkins Medicine

Researchers at Wilmer Eye Institute, Johns Hopkins Medicine say they have evidence that an experimental drug may prevent or slow vision loss in people with diabetes. The results are from a study that used mouse as well as human retinal organoids and eye cell lines.

Newswise: AI Used to Advance Drug Delivery System for Glaucoma and Other Chronic Diseases
Released: 24-May-2023 9:00 AM EDT
AI Used to Advance Drug Delivery System for Glaucoma and Other Chronic Diseases
Johns Hopkins Medicine

Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have used artificial intelligence models and machine-learning algorithms to successfully predict which components of amino acids that make up therapeutic proteins are most likely to safely deliver therapeutic drugs to animal eye cells.

   
Newswise: SpaceMarkers Novel AI Method Identifies Locations, Interactions Among Genes in and Around Tumors
Released: 11-May-2023 11:00 AM EDT
SpaceMarkers Novel AI Method Identifies Locations, Interactions Among Genes in and Around Tumors
Johns Hopkins Medicine

SpaceMarkers, a new machine learning software developed by researchers at the Johns Hopkins Convergence Institute and the Johns Hopkins Kimmel Cancer Center, can identify molecular interactions among distinct types of cells in and around a tumor.

Newswise: News Tip: May Is National Osteoporosis Awareness And Prevention Month — Johns Hopkins Medicine Endocrinologists Are Available for Interviews
Released: 11-May-2023 9:25 AM EDT
News Tip: May Is National Osteoporosis Awareness And Prevention Month — Johns Hopkins Medicine Endocrinologists Are Available for Interviews
Johns Hopkins Medicine

Osteoporosis — a condition that causes bones to become weak and more susceptible to fracture — affects more than 10 million Americans. It occurs when a person’s body does not properly replenish the components of their bone tissue.

Newswise: News Tip: May Is National Hepatitis Awareness Month — Johns Hopkins Medicine Experts Are Available for Interviews
Released: 10-May-2023 11:20 AM EDT
News Tip: May Is National Hepatitis Awareness Month — Johns Hopkins Medicine Experts Are Available for Interviews
Johns Hopkins Medicine

Hepatitis is inflammation of the liver, anorgan that helps digest food and remove toxins from the body. This condition is most commonly caused by viral infection, and many cases clear up within a few months. However, according to the National Institutes of Health, chronic hepatitis — cases that last six months or longer — affects approximately 4.4 million Americans.

Newswise:Video Embedded study-of-cancer-metastasis-most-common-cause-of-cancer-death-gets-35-million-boost-at-johns-hopkins-medicine
VIDEO
Released: 10-May-2023 9:25 AM EDT
Study of Cancer Metastasis, Most Common Cause of Cancer Death, Gets $35 Million Boost at Johns Hopkins Medicine
Johns Hopkins Medicine

With a $35 million gift from researcher, philanthropist and race car driver Theodore Giovanis, scientists at Johns Hopkins Medicine will study the biological roots of the most fatal aspect of cancer: how it metastasizes, or spreads, through the body.

Newswise: Lack of Belief in Body’s Ability to Function Through Pain Linked to Daily Pre-Surgery Prescribed Opioid Use Among Candidates for Elective Spine Surgery
Released: 9-May-2023 11:00 AM EDT
Lack of Belief in Body’s Ability to Function Through Pain Linked to Daily Pre-Surgery Prescribed Opioid Use Among Candidates for Elective Spine Surgery
Johns Hopkins Medicine

According to a new Johns Hopkins Medicine study, low pain self-efficacy can predict daily pre-surgery prescribed opioid use among patients seeking elective spine surgery.

Newswise: Long Telomeres, the Endcaps on DNA, Not the Fountain of Youth Once Thought — Scientists May Now Know Why
2-May-2023 10:05 AM EDT
Long Telomeres, the Endcaps on DNA, Not the Fountain of Youth Once Thought — Scientists May Now Know Why
Johns Hopkins Medicine

In a study of 17 people from five families, Johns Hopkins Medicine researchers say they found that ultra-lengthy DNA endcaps called telomeres fail to provide the longevity presumed for such people. Instead, people with long telomeres tend to develop a range of benign and cancerous tumors, as well as the age-related blood condition clonal hematopoiesis.

Newswise: New Study May Advance Use of Spinal Cord Stimulation for Chemotherapy-Related Pain and Cancer Treatment
Released: 27-Apr-2023 11:30 AM EDT
New Study May Advance Use of Spinal Cord Stimulation for Chemotherapy-Related Pain and Cancer Treatment
Johns Hopkins Medicine

Researchers at Johns Hopkins University School of Medicine say they have evidence from a new study in rats that spinal cord stimulation (SCS) may be useful in reducing chronic pain in people undergoing active treatment with a common anti-cancer drug.

Newswise: Changes in Father’s Sperm Linked to Autistic Traits in Their Children, Small Preliminary Study Suggests
Released: 27-Apr-2023 10:00 AM EDT
Changes in Father’s Sperm Linked to Autistic Traits in Their Children, Small Preliminary Study Suggests
Johns Hopkins Medicine

Among families with children diagnosed with autism spectrum disorder, Johns Hopkins University researchers say they have found a link between chemical “marks” on DNA in the sperm of fathers and autistic traits in their 3-year-old children.

Newswise: Walking A Leashed Dog Associated with Risk of Traumatic Brain Injury Among Adults
Released: 25-Apr-2023 10:00 AM EDT
Walking A Leashed Dog Associated with Risk of Traumatic Brain Injury Among Adults
Johns Hopkins Medicine

Johns Hopkins University researchers have found that traumatic brain injuries (TBIs) were the second most common injury among adults treated in U.S. emergency rooms for injuries related to walking a leashed dog from 2001 to 2020.

Released: 24-Apr-2023 11:00 AM EDT
Researchers ID Novel Treatment Pathway for Deadly Pancreatic Cancers
Johns Hopkins Medicine

Researchers at the Johns Hopkins Kimmel Cancer Center identified a novel cell signaling pathway that potentially could be targeted in therapy for patients with aggressive pancreatic cancers.

Newswise: New Study at Johns Hopkins Kimmel Cancer Center Shows Patient/Clinician Identity Differences Are Factor in Cancer Care
Released: 20-Apr-2023 11:00 AM EDT
New Study at Johns Hopkins Kimmel Cancer Center Shows Patient/Clinician Identity Differences Are Factor in Cancer Care
Johns Hopkins Medicine

A new study by researchers at the Johns Hopkins Kimmel Cancer Center in collaboration with Dell Medical School, University of Minnesota, and the Vanderbilt University Medical Center, using a national data sample from the National Institutes of Health All of Us Research Program, revealed that a small but statistically significant proportion of patients with cancer, especially younger and lower-income minorities, disproportionately reported delaying care because of patient/clinician racial, gender and cultural differences.

Newswise: News Tip: April is STI Awareness Month, Johns Hopkins Sexual Health Experts Available for Interviews
Released: 13-Apr-2023 10:00 AM EDT
News Tip: April is STI Awareness Month, Johns Hopkins Sexual Health Experts Available for Interviews
Johns Hopkins Medicine

Every year, millions of people in the U.S. are diagnosed with sexually transmitted infections (STIs), which are infectious diseases spread through sexual contact. Infection rates are particularly high in young people, with half of new cases occurring in people between 15 and 24 years old.



close
0.24441